ZUG, Switzerland, January 29, 2026 — Galderma, the global pure-play dermatology leader, has unveiled ‘Wake Up To Restylane®’, a new global campaign that repositions Restylane® hyaluronic acid (HA) injectables as an always-on beauty regimen rather than a one-time aesthetic procedure. Launched at the IMCAS World Congress 2026 in Paris, the campaign responds to growing consumer demand for natural-looking, effortless results that integrate seamlessly into daily life, supported by more than 30 years of scientific and clinical evidence.
Science Significance
At the core of the campaign is Restylane’s differentiated science, making it the only HA portfolio supported by four distinct technologies—NASHA®, NASHA HD™, OBT™ and SB-NASHA™—engineered to deliver personalized outcomes across contouring, definition, and skin hydration. These technologies allow Restylane gels to closely mimic the skin’s own hyaluronic acid, ensuring natural movement with facial expressions. New clinical data presented at IMCAS 2026 demonstrated Restylane’s versatility and efficacy across multiple facial areas, including the chin, jawline, temples, and décolletage, reinforcing its scientific leadership in injectable aesthetics and its ability to address both structural and skin-quality concerns.
Regulatory Significance
Restylane’s positioning as an “always-on” beauty solution is underpinned by its robust global regulatory footprint and long-standing safety profile. With nearly three decades of regulatory approvals across major markets and extensive post-marketing surveillance, Restylane benefits from well-established compliance with aesthetic injectable regulations. This depth of regulatory experience supports practitioner confidence, especially as new patient populations—such as first-time injectable users—seek treatments that are predictable, reliable, and aligned with evolving safety expectations in aesthetic medicine.
Business Significance
Advertisement
From a commercial perspective, ‘Wake Up To Restylane’ represents a strategic evolution for Galderma, aligning its flagship injectable brand with the broader beauty and lifestyle economy. By reframing injectables as part of a daily beauty mindset, Galderma aims to expand market penetration, particularly among younger and first-time consumers. Insights from research involving over 4,300 consumers and healthcare professionals across Brazil, China, Germany, and the United States highlight that HA injectables remain among the most planned aesthetic procedures globally, with many consumers ranking HA ahead of neuromodulators. This campaign strengthens Restylane’s competitive positioning while supporting sustained growth in the global aesthetics market.
Patients’ Significance
For patients, the campaign emphasizes authentic, confidence-driven beauty rather than dramatic transformation. Many individuals view HA treatments as an act of self-care and emotional well-being, seeking refreshed, hydrated skin that looks healthy rather than “done.” Restylane addresses these expectations by offering customized treatment options that adapt to individual facial dynamics and life stages, including concerns related to weight-loss-associated facial changes and menopause-related skin health. The promise of waking up looking rested and refreshed resonates strongly with patients seeking subtle enhancement and long-lasting results.
Policy Significance
The campaign also reflects broader policy and societal trends shaping the aesthetics sector, including increased emphasis on responsible beauty, informed consent, and evidence-based practice. By highlighting decades of clinical data and real-world use—more than 77 million treatments administered worldwide—Galderma reinforces the importance of science-led innovation in a field often scrutinized for safety and ethics. This approach aligns with evolving healthcare and consumer protection frameworks that prioritize transparency, patient education, and long-term outcomes in cosmetic interventions.
With ‘Wake Up To Restylane’, Galderma signals a shift in how injectable aesthetics are perceived—moving from episodic procedures to integrated beauty solutions rooted in science, personalization, and trust. Backed by extensive clinical evidence and a diversified HA technology platform, Restylane continues to set benchmarks for natural-looking, always-on beauty. As consumer expectations evolve toward authenticity and simplicity, Galderma’s latest campaign positions Restylane at the intersection of dermatology, beauty, and lifestyle, reinforcing its leadership in the global aesthetics landscape.
Source: Galderma Global press release
